【レポートの概要（一部）】
1. Report Overview
1.1 The OTC Pharmaceuticals Market Overview
1.2 OTC Pharmaceuticals Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to OTC Pharmaceuticals
2.1 What are OTC Pharmaceuticals?
2.2 Classification of OTC Pharmaceuticals
2.3 What are the Requirements for an OTC Pharmaceutical Drug?
2.4 OTC Switching
2.4.1 How is a Drug Switched from Prescription to OTC?
2.5 Manufacturing and Distribution of OTC Pharmaceuticals
2.6 Regulation of OTC Pharmaceuticals
2.6.1 Regulation of OTC Pharmaceuticals in the US
2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
2.6.3 Regulation of OTC Pharmaceuticals in Europe
2.6.4 Regulation of OTC Pharmaceuticals in China
2.6.5 Regulation of OTC Pharmaceuticals in Others Countries
2.7 OTC Pharmaceuticals: Market Segmentation
2.7.1 Analgesics
2.7.1.1 Internal Analgesics
2.7.1.2 External Analgesics
2.7.2 Cough, Cold and Allergy Products
2.7.2.1 Cough and Cold Remedies
2.7.2.2 Anti-Allergy Products
2.7.3 Dermatological Products
2.7.3.1 Minor Cuts and Wounds
2.7.3.2 Acne
2.7.3.3 Rashes, Itchy Skin, and Dermatitis/Eczema
2.7.3.4 Cold Sores
2.7.3.5 Warts
2.7.3.6 Fungal Skin Infections
2.7.3.7 Haemorrhoids
2.7.3.8 Other Dermatological Products
2.7.4 Gastrointestinal Products
2.7.4.1 Indigestion and Heartburn
2.7.4.2 Anti-Diarrhoea OTC Pharmaceuticals
2.7.4.3 Laxatives
2.7.4.4 Anti-Emetic OTC Pharmaceuticals
2.7.4.5 Anti-Obesity OTC Pharmaceuticals
2.7.5 Eye Care
2.7.5.1 Dry Eye Syndrome
2.7.5.2 Bacterial Conjunctivitis
2.7.5.3 Ocular Allergy and Allergic Conjunctivitis
2.7.5.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
2.7.6 Smoking Cessation Aids
2.7.7 Vitamins, Minerals and Supplements
3. The World OTC Pharma Market 2015-2025
3.1 The World OTC Pharma Market in 2013 and 2014
3.1.1 OTC Pharma Market Segmentation in 2013 and 2014
3.1.2 Leading OTC Pharma Brands
3.1.3 Leading Companies in the OTC Market
3.2 The World OTC Pharma Market: Sales Forecast, 2015-2025
3.2.1 The World OTC Pharma Market, 2015-2025: Drivers and Restraints
3.3 OTC Pharma Market Segments: Sales Forecasts, 2015-2025
3.3.1 CAGRs by OTC Segment, 2015-2025
3.3.2 Changing Market Shares by OTC Segment, 2015-2025
3.3.3 Cough, Cold and Allergy OTC Market: Sales Forecast 2015-2025
3.3.4 Analgesics OTC Market: Sales Forecast 2015-2025
3.3.5 Gastrointestinal OTC Market: Sales Forecast 2015-2025
3.3.6 Dermatological OTC Market: Sales Forecast 2015-2025
3.3.7 Eye Care OTC Market: Sales Forecast 2015-2025
3.3.8 Smoking Cessation OTC Market: Sales Forecast 2015-2025
3.3.9 Other OTC Market: Sales Forecast 2015-2025
4. The Leading National Markets 2015-2025
4.1 Regional Breakdown of the World OTC Pharma Market in 2013 and 2014
4.2 The World OTC Pharmaceutical Market: Regional Forecast, 2015-2025
4.3 Changing Market Shares of Leading National Markets: Emerging Dominance of China
4.4 The US OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.4.1 The US OTC Pharma Market: Financial Incentives to Using OTC Drugs
4.4.2 The US OTC Pharma Market: Leading Companies
4.5 The Japanese OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.5.1 The Japanese OTC Pharma Market: Deregulation could Stimulate Growth
4.5.2 The Japanese OTC Pharma Market: Leading Companies
4.6 The EU5 OTC Pharma Market in 2013 and 2014
4.6.1 Changing Market Shares of the EU5 OTC Pharmaceuticals Market
4.6.2 The EU5 OTC Market Sales Forecast, 2015-2025
4.6.3 The EU5 OTC Pharma Market: Leading Companies
4.6.4 The German OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.5 The UK OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.5.1 The UK’s Liberal OTC Regulations
4.6.6 The French OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.6.1 OTC Drugs: A French Monopoly System
4.6.7 The Italian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.8 The Spanish OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.7 The Chinese OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.7.1 The Chinese OTC Pharma Market: Leading Companies
4.7.2 The Role of Traditional Chinese Medicines (TCM) in the Chinese OTC Market
4.8 The Brazilian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.8.1 The Brazilian OTC Pharma Market: Leading Companies
4.8.2 The Brazilian OTC Pharma Market: An Overview
4.9 The Russian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.9.1 The Russian OTC Pharma Market: Leading Companies
4.9.2 The Russian OTC Pharma Market: Overview
4.10 The Indian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.10.1 The Indian OTC Pharma Market: Leading Companies
4.10.2 The Indian OTC Pharma Market: An Overview
4.11 The Mexican OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.11.1 Mexican OTC Manufacturers Reach New Heights
4.12 The Turkish OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.13 The Indonesian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.14 The Rest of the World OTC Pharmaceutical Market Sales Forecast, 2015-2025
5. Leading Companies in the OTC Pharma Market 2015-2025
5.1 Leading OTC Pharmaceutical Manufacturers, 2013
5.1.1 Projected Leading OTC Pharmaceutical Manufacturers, 2015
5.2 GSK (Joint Venture with Novartis)
5.2.1 GSK Consumer Healthcare Unit: Historical Activity
5.2.2 GSK and Novartis Combine their OTC Businesses
5.2.3 GSK/Novartis: Additional Transactions
5.2.4 GSK Consumer Healthcare: OTC Sales Forecast, 2015-2025
5.2.5 Panadol
5.2.5.1 Panadol: Sales Forecast, 2015-205
5.2.6 Alli: A Beleaguered Brand
5.2.6.1 GSK Smoking Cessation Products
5.3 Novartis (OTC Joint Venture with GSK)
5.3.1 Novartis: Transformational Year
5.3.2 Voltaren
5.3.2.1 Voltaren: Sales Forecast 2015-2025
5.4 Bayer
5.4.1 Acquisition of Merck’s Consumer Care Business, 2014
5.4.2 Bayer: OTC Sales Forecast, 2015-2025
5.4.3 Bayer Aspirin
5.4.4 Bayer Aspirin: Sales Forecast 2015-2025
5.5 Merck (Acquired by Bayer)
5.5.1 Claritin OTC (Loratadine)
5.6 Johnson and Johnson
5.6.1 FDA Governance of McNeil Manufacturing Activity
5.6.2 Expansion in Developing Markets through Acquisitions
5.6.3 Johnson & Johnson: OTC Sales Forecast, 2015-2025
5.6.4 Tylenol
5.6.5 Tylenol: Sales Forecast, 2015-2025
5.6.6 Nicorette
5.7 Perrigo
5.7.1 Perrigo: OTC Sales Forecast, 2015-2025
5.7.2 Perrigo: Growth by Acquisition
5.7.3 Perrigo Bids for Omega Pharma
5.7.4 Perrigo’s Product Launches in FY 2013
5.7.5 Perrigo Benefits from Challenges Faced by J&J
5.8 Pfizer
5.8.1 Pfizer: OTC Sales Forecast, 2015-2025
5.8.2 Pfizer Acquires Rights to AstraZeneca’s OTC Nexium
5.8.3 Pfizer: Bulking up their OTC Product Portfolio
5.8.4 Advil
5.8.5 Advil: Sales Forecast, 2015-2025
5.9 Procter & Gamble
5.9.1 PGT Healthcare- Procter& Gamble’s Joint Venture with Teva
5.9.2 Prilosec OTC
5.9.3 Major Plans for Divestment Including OTC Products
5.10 Reckitt Benckiser
5.10.1 Reckitt Benckiser: OTC Sales Forecast, 2015-2025
5.10.2 Internal Growth by “Power” Brand Extensions: Mucinex
5.10.3 Expanding Presence in Emerging Markets through Acquisition
5.11 Sanofi
5.11.1 Sanofi: Acquisition of OTC Products from J&J
5.11.2 Sanofi: Launch of Nasacort
5.11.3 Sanofi: OTC Sales Forecast, 2015-2025
5.12 Boehringer Ingelheim
5.12.1 Boehringer Ingelheim: OTC Sales Forecast, 2015-2025
6. OTC Switching and Potential Future OTC Drugs
6.1 OTC Switching: An Overview
6.1.1 What is OTC Switching?
6.1.2 Which Products Will Switch?
6.1.3 How Does OTC Switching Occur?
6.1.4 How Does OTC Switching Affect The OTC Pharma Market?
6.1.5 Opposition to OTC Switching
6.2 OTC Switching Activity, 2002-2014
6.2.1 OTC Switching: Downward Trend
6.2.2 The FDA NSURE Initiative: Reversing the Downward Trend in Rx-to-OTC Switches
6.3 Potential Candidates for OTC Switching 2015-2025
6.4 Cough, Cold and Allergy: OTC Switches
6.4.1 First-Generation Antihistamines
6.4.2 Allegra (fexofenadine)
6.4.3 Clarinex (desloratadine)
6.4.4 Flixotide/Flonase (fluticasone): Latest Nasal Corticosteroid Approval
6.4.5 Nasacort (triamcinolone): First in Class U.S. OTC Approval
6.5 Analgesics: OTC Switch Limitations
6.5.1 Triptans: The U.S. Will Remain Cautious
6.5.2 NSAIDs for Arthritis: Safety Concerns Incites Reverse-Switching
6.5.3 Other Analgesics
6.6 Gastrointestinals: OTC Switches
6.6.1 H2-Receptor Blockers
6.6.2 Proton pump inhibitors (PPIs)
6.6.2.1Omeprazole
6.6.2.2 Lansoprazole
6.6.2.3 Pantoprazole
6.6.2.4 Esomeprazole: 2014 U.S. FDA Approval for OTC Use
6.6.2.5 Rabeprazole
6.6.3 Anti-obesity drugs
6.7 Dermatologicals: OTC Switches
6.7.1 Antivirals for Oral Herpes Simplex
6.8 Anticholinergics for Incontinence: OTC Switches
6.9 Oral Contraceptives: An OTC Switch Can have Significant Economic Benefits
6.10 High Demand for OTC Cholesterol-Lowering Drugs
6.10.1 Lipitor (atorvastatin): Testing Times for Pfizer
6.10.2 Zocor Heart Pro (simvastatin) in the UK
6.10.3 OTC Statins: U.S. Historical Setbacks
6.11 Other Potential OTC Switch Categories
6.11.1 High blood pressure: Thiaside Diuretics
6.11.2 Erectile Dysfunction: Viagra (sildenafil), Cialis (tadalafil)
6.11.3 Osteoporosis: (Bisphosphonates) An Undertreated Disease, but a Very Unlikely OTC Switch
6.11.4 Insomnia: Silenor (doxepin)
7. Qualitative Analysis of the OTC Pharma Market, 2015-2025
7.1 SWOT Analysis of the OTC Pharmaceutical Market
7.2 Strengths
7.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
7.2.1.1 Manufacturers can Reap OTC Sales Benefits
7.2.1.2 Third Party Payers: Reducing the Cost Burden
7.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
7.2.2 Many Pharma Companies Have a Strong Potential OTC Portfolio
7.2.3 Regulators Are Encouraging OTC Approvals
7.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
7.2.5 Deterring the Consumption of Counterfeit Drugs
7.2.6 Cultural Changes Will Support Self-Medication With OTC Medicines
7.3 Weaknesses
7.3.1 Pharma Companies Remain Focused on Prescription Drugs
7.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
7.3.3 OTC Products are Vulnerable to Price Controls by Governments
7.3.4 Downward Cost Pressures of OTC Drugs
7.4 Opportunities
7.4.1 Demographic and Economic Changes Will Create Growth Opportunities
7.4.2 New OTC Switch Categories
7.4.3 Strong Growth in Emerging Markets
7.4.4 New Healthcare Technologies May enable OTC Approvals
7.4.5 Opportunities to Drive Sales Via Social Media and Online Marketing
7.4.6 Self Medication can Reduce the Under Treatment of Disease
7.5 Threats
7.5.1 Competition from Private-Label Brands Will Reduce Profitability
7.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
7.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
7.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market
7.6.1 Rivalry Among Competitors [High]
7.6.2 Threat of New Entrants [Medium]
7.6.3 Power of Suppliers [Low]
7.6.4 Power of Buyers [Medium]
7.6.5 Threats of Substitutes [Medium]
8. Expert Opinions
8.1 Interview with Professor Joshua P. Cohen, PhD, Tufts Center for the Study of Drug
Development, Boston, Massachusetts, USA
8.1.1 Major OTC Consolidation
8.1.2 The Creation of a Behind the Counter Class in the U.S.
8.1.3 Future Rx-OTC Switches
8.1.4 Prospects for OTC Statins in the U.S.
8.1.5 The NSURE (Non-Prescription Safe Use Regulatory Expansion) Initiative
8.1.6 The Rate of OTC Switching
8.1.7 American Consumers Perception of OTC Drugs
8.1.8 The Under-treatment of Disease in America
8.1.9 Health Impacts of Potential Rx-OTC Switching
8.1.10 The U.S OTC Regulatory Process- Too Stringent?
8.2 Interview with Mr David Spangler, Senior Vice President, US Consumer Health Products
Association, Washington DC, USA
8.2.1 Prospects for a Behind-the-Counter Class of OTC Drugs in the US
8.2.2 Obama’s Affordable Care Act and the OTC Industry
8.2.3 Major Restraints on Pharma OTC Growth
8.2.4 Shifting Formal Healthcare to the Retail
9. Conclusions
9.1 The World OTC Pharma Market in 2013-2014
9.1.1 The Leading OTC Product Categories
9.1.2 Leading OTC Pharma Brands, 2013
9.1.3 Leading OTC Manufacturers
9.1.4 Leading National Markets: Emerging Market Represent a Large Proportion
9.1.5 The Global OTC Market Growth Factors
9.1.6 Potential OTC Switching, 2015-2025
9.1.7 Emerging OTC Markets
9.2 Concluding Remarks
【レポート販売概要】
■ タイトル：OTC医薬品（一般用医薬品）の世界市場■ 英文：World OTC Pharmaceuticals Market Forecast 2015-2025 : Prospects For Leading Companies
■ 発行日：2014年12月
■ 調査会社：visiongain
■ 商品コード：VGAIN4121911
■ 調査対象地域：グローバル
- 産業用PCの世界市場予測（～2022年）：パネルPC、ラックマウントPC、ボックスPC、エンベデッドPC、エンベデッドパネルPC、DINレールPC“Industrial PC market to exhibit significant growth between 2016 and 2022”The industrial PC was valued at USD 3.30 billion in 2016 and is expected to grow at a CAGR of 6.2% to reach USD 4.73 billion by 2022. The growth in this market can be attributed to the increasing penetration of IoT across manufacturing industries, high R&D investments by the manufacturing companies to promote the adoption of …
- Occidental Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Occidental Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Occidental Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report …
- タイル接着剤の世界市場予測Tile adhesive is used to join two substrates and offer excellent chemical resistance, shock & impact resistance, high bond strength, and ultimate flexibility. The tile adhesive works on the basis of cohesive mechanisms and adhesion mechanisms.The tile adhesive market across the world is expected to reach USD 3338.2 million by the end of 2023. The growth of the tile adhesive market can be attribute …
- セルロースエーテル及び誘導体の世界市場：メチルセルロース、エチルセルロース、HEC、HPC、CMCThe global cellulose ether & derivatives market size, in terms of value, is projected to reach USD 6.30 Billion, by 2020, at a CAGR of 7.2%, between 2015 and 2020. The high-growth application areas such as personal care, pharmaceuticals, construction, food ingredients, and continuous expansion and merger & acquisition activities undertaken by companies are key factors driving the growth of the cel …
- 自動車ビッグデータの世界市場予測2016-2026This new report from business intelligence provider visiongain offers insightful analysis of the global automotive big data market. Visiongain assesses that the revenue of the automotive big data market will exceed $4.7 billion in 2016. Automotive Big Data is undeniably one of the fastest growing submarkets in the car safety and security sector. What will you discover from this report? • How will …
- 脳室周囲白質軟化症治療のグローバル臨床試験動向（2014年下半期）Periventricular Leukomalacia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Periventricular Leukomalacia Global Clinical Trials Review, H2, 2014" provides data on the Periventricular Leukomalacia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Periventricular Leukomalacia. It includes an overview …
- 屋根用タイルの世界市場：クレイタイル、コンクリートタイルAbout the Roofing Tiles Market A roofing tile provides protection to the structure below from heat and rain. Modern day roofing tiles are available in a variety of shapes and sizes to provide an aesthetic appeal to the overall building. These tiles can be fixed onto the roof through either nails or even cement at select points of the tile. Technavio’s analysts forecast the global thoracic surgery …
- キノコの世界市場：ボタン・マッシュルーム、シイタケ、ヒラタケThe mushroom market has grown exponentially in the last few years and this trend is projected to continue. The market was valued at $29,427.92 million in 2013; and at a CAGR of 9.5% from 2014, it is projected to reach $50,034.12 million by 2019. The market is being driven by the rise in consumption of processed food, rise in consumer awareness about health and wellness, cultivation being a promisi …
- エラストマー塗料の世界市場：アクリル系エラストマー塗料、ポリウレタン系エラストマー塗料、シリコーン系エラストマー塗料、ブチル系エラストマー塗料The global elastomeric coating market is projected to reach USD 13.58 Billion by 2021, registering a CAGR of 15.19% between 2016 and 2021. The global elastomeric coating market, along with its types and applications, witnessed a significant growth in the past few years and is estimated to continue in the coming years. An increase in demand from the construction industry because of its superior per …
- 商業用空港照明の世界市場2019-2023About this market Construction of new airports and modernization of existing airport infrastructure will be key factor driving the growth of the global commercial airport lighting market. Many countries are investing in new and improved infrastructure to manage the growing air traffic and maintain high level of service. Countries are focusing on renovating their airport infrastructure to modernize …
- 世界の非接触型決済市場（技術進歩、予測、分析）The increasing requirement of the consumers to make online payments and payments via mobile phones is helping the society tomove toward a cashless society. Financial institutions are offering various types of payment services tending people to use more of cards and mobile phones for payments. The potential marketing strategies provided by various business segment and payments market is changing th …
- 中国のヒートポンプ市場：Heat Pump Market in China 2014-2018TechNavio's analysts forecast the Heat Pump market in China to grow at a CAGR of 27.86 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for a reduction of greenhouse gases. The Heat Pump market in China has also been witnessing the increasing awareness of the latest technology. However, the need for high initial investment could pose a challe …
- 高電圧機器の世界市場：電力変圧器、開閉装置、スイッチ、制御装置、無効電力装置、計器用変成器、リレーパネル、接地装置、電池セットThis report estimates the high voltage equipment market size in terms of value in $billion. The market for High Voltage Equipment in the report has been segmented into by regions and further split into key countries. High voltage equipment market has also been segmented on the basis of voltage level for which they are designed for different voltage level such as Ultra High Voltage (UHV), Extra Hig …
- 世界の軍事用電気光学・赤外線市場（2014-2024）：主要プロジェクトSynopsis This report provides information on major programs planned in the global Military Electro Optical Infrared (EO/IR) market. It provides details on top programs in each segment expected to be executed during the forecast period. Summary This report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Military Electro Optical Infrar …
- 自動ラストマイルデリバリーの世界市場：用途別（ロジスティクス、ヘルスケア＆医薬品、食品＆飲料小売、その他）、ソリューション別（ハードウェア、ソフトウェア、サービス）、範囲別（短距離（20km））、車両タイプ別（空中配達ドローン、地上配達車両、自動運転トラック＆バス）Autonomous last mile delivery consists of autonomous vehicles to deliver the product or service to customer’s doorstep without actually involving any human intervention in the entire process. It ensure that the product is delivered to the customer within a stipulated time period without hampering the dignity and market image of the company. Increased usage of internet along with the expansion in e …
